Peter A. Everts
www.linkedin.com
0000-0003-3128-9380
Max-Planck University
57 papers found
Refreshing results…
Platelet-Rich Plasma Power-Mix Gel (ppm)—An Orthobiologic Optimization Protocol Rich in Growth Factors and Fibrin
Angiogenesis and Tissue Repair Depend on Platelet Dosing and Bioformulation Strategies Following Orthobiological Platelet-Rich Plasma Procedures: A Narrative Review
Basic Science of Allograft Orthobiologics
Basic Science of Autologous Orthobiologics
Modifying Orthobiological PRP Therapies Are Imperative for the Advancement of Treatment Outcomes in Musculoskeletal Pathologies
Bone Marrow Aspirate Concentrate Is Equivalent to Platelet-Rich Plasma for the Treatment of Knee Osteoarthritis at 2 Years: A Prospective Randomized Trial
Autologous Tissue Harvesting Techniques: Platelet Rich Plasma
Autologous Orthobiologics
Novel autologous, high concentrated fibrin as advanced hemostatic agent for coronary surgery
Platelet Rich Plasma in Orthopedic Surgical Medicine.
Pain and functional outcomes of the sacroiliac joint after platelet-rich plasma injection: a descriptive review
Proteomic analysis of platelet-rich and platelet-poor plasma
Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020
Laboratory Quantification of Bone Marrow Concentrate Components in Unilateral Versus Bilateral Posterior Superior Iliac Spine Aspiration
A Comparative Quantification in Cellularity of Bone Marrow Aspirated with two New Harvesting Devices, and The Non-equivalent Difference Between A Centrifugated Bone Marrow Concentrate And A Bone Marrow Aspirate As Biological Injectates, Using A Bi-Lateral Patient Model
Role of Mechanical Loading for Platelet-Rich Plasma-Treated Achilles Tendinopathy
The Rationale of Autologously Prepared Bone Marrow Aspirate Concentrate for use in Regenerative Medicine Applications
Bone Marrow Aspirate Concentrate Is Equivalent to Platelet-Rich Plasma for the Treatment of Knee Osteoarthritis at 1 Year: A Prospective, Randomized Trial
Assessing clinical implications and perspectives of the pathophysiological effects of erythrocytes and plasma free hemoglobin in autologous biologics for use in musculoskeletal regenerative medicine therapies. A review
Missing publications? Search for publications with a matching author name.